Change over period: —
NSE · SANOFI
SANOFI
-30.0% from the 52-week high · +16.6% above the low
Sanofi India Ltd. engages in the manufacturing and distribution of pharmaceutical drugs. The company is headquartered in Mumbai, Maharashtra and currently employs 3,530 full-time employees. The firm is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. The company has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. The company sells its products through independent distributors primarily in India. The company also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.
The short version. SANOFI reported revenue of ₹515 crore for Dec 2024, down 25.8% from a year earlier. Net profit was ₹91 crore (down 34.1% year on year). Promoter holding was 60.4% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
SANOFI trades 30.0% below its 52-week high and 16.6% above its 52-week low.
2 · The business
Is it growing?
Dec 2024 revenue of ₹515 cr.
Dec 2024 net profit of ₹91 cr.
2.1 pts lower than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|
| Revenue | 515 | 524 | 464 | 732 | 694 | 715 | 706 |
| Net profit | 91 | 82 | 103 | 137 | 138 | 152 | 123 |
| Net margin % | 17.7 | 15.7 | 22.3 | 18.7 | 19.8 | 21.3 | 17.4 |
| EPS (₹) | 39.64 | 35.69 | 44.81 | 59.31 | 59.79 | 65.98 | 53.36 |
Annual
| Dec 2024 | Dec 2023 | |
|---|---|---|
| Revenue | 2013 | 2851 |
| Net profit | 413 | 603 |
| Net margin % | 20.5 | 21.1 |
| EPS (₹) | 179.46 | 261.78 |
3 · The quality
How well does it turn capital into profit?
.
Profitability · 4 years
Returns and margins
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Return on equity % | — | 48.0 | 59.4 | — |
| Return on capital % | — | 48.5 | 79.7 | — |
| EBITDA margin % | — | 23.1 | 30.4 | — |
| Net margin % | — | 20.4 | 20.7 | — |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
Up 0.1 pts over 8 quarters.
Down 3.52 pts over 8 quarters.
+3 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 60.4 | 0.0 |
| FII | 5.63 | 5.57 | 5.61 | 5.57 | 5.55 | 5.64 | 5.69 | 5.73 | +0.1 |
| DII | 22.93 | 23.02 | 23.06 | 22.29 | 21.31 | 21.13 | 19.87 | 19.41 | -3.52 |
| Public | 11.04 | 11.01 | 10.94 | 11.75 | 12.74 | 12.83 | 14.04 | 14.46 | +3.42 |
Mutual fund holdings · Oct 2026
19 schemes hold this stock
16 the month before.
- Bandhan Healthcare Fund1.58% of NAV
- Abakkus Small Cap Fund1.15% of NAV
- NIPPON INDIA PHARMA FUND1.06% of NAV
- Sundaram Dividend Yield Fund0.49% of NAV
- ADITYA BIRLA SUN LIFE BALANCED ADVANTAGE FUND0.42% of NAV
- ADITYA BIRLA SUN LIFE LARGE CAP FUND0.39% of NAV
- SAMCO MULTI CAP FUND0.36% of NAV
- Bandhan Flexi Cap Fund0.24% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SANOFI are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about SANOFI
What is the SANOFI share price?
SANOFI (SANOFI) last closed at ₹3,202.50, down 0.91% on the day. Its 52-week range is ₹2,772.80 to ₹4,614.20.
What is the market cap of SANOFI?
SANOFI has a market capitalisation of about ₹7,443 crore. Its price-to-earnings ratio is 20.5.
How are SANOFI's latest results?
SANOFI reported revenue of ₹515 crore for Dec 2024, down 25.8% from a year earlier. Net profit was ₹91 crore (down 34.1% year on year). Promoter holding was 60.4% in Sep 2026, up 0.00 points over 8 quarters.
Who owns SANOFI?
As of Sep 2026, shareholding was: Promoter 60.4%, FII 5.73%, DII 19.41%, Public 14.46%.
How many mutual funds hold SANOFI?
19 mutual fund schemes held SANOFI in October 2026. That compares with 16 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 22 Apr 2026 · Final Dividend - Rs. 48
- 07 Nov 2025 · Interim Dividend - Rs. 75
- 25 Apr 2025 · Final Dividend - Rs. 117
- 03 May 2024 · Final Dividend - Rs. 117
- 07 Mar 2024 · Interim Dividend - Rs. 50
- 28 Apr 2023 · Final Dividend - Rs. 194
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.